Skip to main content
Home
  • About
    • Board of Directors
    • Our Staff
    • Annual Reports
    • Policies
    • Fellowship
    • Careers
  • Projects
    • Column 1
      • Animal Health & Veterinary Medicine
        • Antimicrobial Use in Food Animals
        • Cross-Sectoral Health Threats
        • Industry SWOT Analysis
      • Expanded Access
        • E-request App
        • Navigator
        • Resources for COVID-19
      • FDA Patient Listening Sessions
      • Food & Nutrition
        • About
        • Food Traceability
        • Healthy Rule Roundtables
        • Nutrition Facts Label
        • Produce Safety Stakeholder Dialogue
        • Retail Dietitian Toolkit
    • Column 2
      • Improving Access to FDA Information
        • Understanding FDA & FDA-Regulated Products
        • Improving Access to Publicly Available FDA Information
      • Research
        • About
        • IMEDS
          • IMEDS Inquiry
        • Post Market Research
        • RAISE
        • Real World Data
        • Regulatory Science Accelerator
      • Substance Use Disorders
  • News and Events
    • Innovations in Regulatory Science & Policy Awards
    • 2025 Annual Public Meeting
    • Events
    • News
    • Publications
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
      1. Board of Directors
      2. Our Staff
      3. Annual Reports
      4. Policies
      5. Fellowship
      6. Careers
  • Projects
      1. Column 1
        1. Animal Health & Veterinary Medicine
          1. Antimicrobial Use in Food Animals
          2. Cross-Sectoral Health Threats
          3. Industry SWOT Analysis
        2. Expanded Access
          1. E-request App
          2. Navigator
          3. Resources for COVID-19
        3. FDA Patient Listening Sessions
        4. Food & Nutrition
          1. About
          2. Food Traceability
          3. Healthy Rule Roundtables
          4. Nutrition Facts Label
          5. Produce Safety Stakeholder Dialogue
          6. Retail Dietitian Toolkit
      2. Column 2
        1. Improving Access to FDA Information
          1. Understanding FDA & FDA-Regulated Products
          2. Improving Access to Publicly Available FDA Information
        2. Research
          1. About
          2. IMEDS
          3. Post Market Research
          4. RAISE
          5. Real World Data
          6. Regulatory Science Accelerator
        3. Substance Use Disorders
  • News and Events
      1. Innovations in Regulatory Science & Policy Awards
      2. 2025 Annual Public Meeting
      3. Events
      4. News
      5. Publications
  • Expanded Access eRequest

Treatment of Non-severe Covid-19 Outpatients With Xagrotin, Phase 3

  • Read more about Treatment of Non-severe Covid-19 Outpatients With Xagrotin, Phase 3

Intersectoral Platform (SÜP) of the National Pandemic Cohort Network (NAPKON)

  • Read more about Intersectoral Platform (SÜP) of the National Pandemic Cohort Network (NAPKON)

Clinical Validation of the LumiraDx SARS-CoV-2 & Flu A/B Test in Detecting and Differentiating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Influenza A (Flu A), and/or Influenza B (Flu B)

  • Read more about Clinical Validation of the LumiraDx SARS-CoV-2 & Flu A/B Test in Detecting and Differentiating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Influenza A (Flu A), and/or Influenza B (Flu B)

Dapsone Coronavirus SARS-CoV-2 Trial (DAP-CORONA) COVID-19

  • Read more about Dapsone Coronavirus SARS-CoV-2 Trial (DAP-CORONA) COVID-19

Sisonke 2 - A COVID-19 Vaccine Boost Open Label Study.

  • Read more about Sisonke 2 - A COVID-19 Vaccine Boost Open Label Study.

Sleep Quality and Quality of Life in Coronavirus 19 Disease ( COVID 19) Patients

  • Read more about Sleep Quality and Quality of Life in Coronavirus 19 Disease ( COVID 19) Patients

Booster Superiority Study of PTX-COVID19-B Compared to Vaxzevria® in Adults Aged 18 Years and Older

  • Read more about Booster Superiority Study of PTX-COVID19-B Compared to Vaxzevria® in Adults Aged 18 Years and Older

Identification of Novel Factors Leading to Activated Macrophage Expansion in COVID19 - INFLAME Study

  • Read more about Identification of Novel Factors Leading to Activated Macrophage Expansion in COVID19 - INFLAME Study

COVID-19 Vaccination Status and The Clinical Outcomes of Long COVID-19 Patients

  • Read more about COVID-19 Vaccination Status and The Clinical Outcomes of Long COVID-19 Patients

Impact of Genetic Polymorphisms of Vasoactive Peptides on the Prognosis of Patients With COVID19

  • Read more about Impact of Genetic Polymorphisms of Vasoactive Peptides on the Prognosis of Patients With COVID19

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 169
  • Page 170
  • Page 171
  • Page 172
  • Current page 173
  • Page 174
  • Page 175
  • Page 176
  • Page 177
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
admin@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA